E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/6/2010 in the Prospect News Structured Products Daily.

New Issue: UBS prices $8.92 million 14.43% yield optimization notes tied to Boston Scientific

By Marisa Wong

Milwaukee, May 6 - UBS AG, London Branch priced $8.92 million of 14.43% yield optimization notes with contingent protection due May 11, 2011 linked to the common stock of Boston Scientific Corp., according to a 424B2 filing with the Securities and Exchange Commission.

Each note priced at par of $6.76, which was the closing price of Boston Scientific stock on the pricing date.

Interest is payable monthly.

If the final price of Boston Scientific stock is greater than or equal to 80% of the initial price, the payout at maturity will be par. Otherwise, the payout will be one Boston Scientific share per note.

UBS Financial Services Inc. and UBS Investment Bank are the underwriters.

Issuer:UBS AG, London Branch
Issue:Yield optimization notes with contingent protection
Underlying stock:Boston Scientific Corp. (Symbol: BSX)
Amount:$8,920,827.24
Maturity:May 11, 2011
Coupon:14.43%, payable monthly
Price:Par of $6.76
Payout at maturity:If share price finishes below trigger price, one Boston Scientific share; otherwise, par
Initial price:$6.76
Trigger price:$5.41, 80% of initial price
Pricing date:May 5
Settlement date:May 10
Underwriters:UBS Financial Services Inc. and UBS Investment Bank
Fees:2%
Cusip:90267C243

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.